GSK vs SXI · P/E 13, $103.31B cap vs P/E 35, rev $891.6M
GlaxoSmithKline PLC ADR (GSK) versus Standex International Corporation (SXI) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Standex International Corporation (SXI) is a specialty industrial machinery company listed on US.
GSK does not have a complete income-statement cache yet.
Latest reported SXI revenue for 2026-06-30 was $891.6M. Net income was $104.6M. Revenue was up 12.8% from 2025-06-30 to 2026-06-30. SXI currently screens at market cap $3.52B and trailing P/E 35.3.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. SXI currently screens at market cap $3.52B and trailing P/E 35.3.
Not investment advice. Open the GSK and SXI stock pages for the full models.
Not investment advice.